Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polysaccharide meningococcal vaccines--current status.

R Gold

    Hospital Practice
    |December 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Two imperfect meningococcal vaccines against serogroups A and C exist, but a Group B vaccine is needed for disease control. Research continues to address this gap in meningococcal vaccines.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Rapid differentiation of MOGAD and MS after a single optic neuritis.

    Journal of neurology·2024
    Same author

    Characteristic retinal atrophy pattern allows differentiation between pediatric MOGAD and MS after a single optic neuritis episode.

    Journal of neurology·2022
    Same author

    Bilateral giant cell arteritis with skin necrosis following SARS-CoV-2 vaccination.

    The British journal of dermatology·2021
    Same author

    Pathological spontaneous activity as a prognostic marker in chronic inflammatory demyelinating polyneuropathy.

    European journal of neurology·2020
    Same author

    The impact of a nationwide hands-on workshop on the diagnostic rates and management of obstetrical anal sphincter Injuries in Israel.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2020
    Same author

    Atrophy of optic nerve detected by transorbital sonography in patients with demyelinating diseases of the central nervous system.

    European journal of neurology·2019

    Area of Science:

    • Microbiology
    • Vaccinology
    • Epidemiology

    Background:

    • Neisseria meningitidis causes bacterial meningitis, a serious infection.
    • Antimeningococcal vaccines against serogroups A and C have been developed.
    • These vaccines are effective for epidemic control but not for routine use.

    Purpose of the Study:

    • To review the development and efficacy of current antimeningococcal vaccines.
    • To highlight the ongoing challenge of developing a Group B vaccine.

    Main Methods:

    • Review of historical research periods and vaccine development.
    • Analysis of vaccine effectiveness in epidemic control.

    Main Results:

    • Two effective, yet imperfect, vaccines against serogroups A and C have been produced.

    Related Experiment Videos

  • These vaccines have successfully halted meningococcal disease epidemics.

    • Conclusions:

    • Current vaccines against serogroups A and C are valuable tools for outbreak control.
    • The absence of an effective Group B immunogen remains a significant barrier to controlling meningococcal disease.